AI-generated summary
This review examined published studies on photobiomodulation (laser therapy) in multiple sclerosis, searching several databases for related work. The authors report that photobiomodulation may affect inflammation, immune cell activity, mitochondrial function and free radical production, with reduced neurological defects and improved functional status. The abstract does not report a count of included studies or participants.
- Who or what was studied
- Patients with multiple sclerosis (review of published studies; population details not specified)
- Limits stated in the abstract
- The abstract does not state the number of included studies, their designs, or the certainty of the evidence, and the exact mechanisms are described as not fully understood.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser, Low-level laser therapy, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.